Prostate cancer in Mexico: epidemiologic experience at the Nuevo Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”

Abstract

Aim: To know the epidemiology, treatment, and follow-up of patients with prostate cancer at the Nuevo Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”.

Materials and methods: A retrospective, descriptive, observational study was conducted on 196 patients with prostate cancer that were seen within the time frame of 2015 and 2020 at the Nuevo Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”.

Results: Of the 196 cases analyzed, mean age at disease presentation was 72.02 years (±8.77), 53.5% did not have a primary school educational level, and 87.7% had no formal employment. Mean body mass index was 25.43 kg/m2 (±3.13) and the most frequent risk factors were smoking, high blood pressure, and diabetes mellitus. Mean prostate-specific antigen level before treatment was 17.59 ng/ml. Of the cases treated, 31.07% underwent surgery, 55.05% received hormone therapy, and 1.02% were under surveillance. Only 12 cases (6.12%) of death were associated with prostate cancer and 37.75% of the study population was lost to follow-up.

Study limitations: Sample size, single-center study. 

Value: Ours is a recent epidemiologic study on prostate cancer in Guadalajara, Jalisco.

Conclusions: There was a high degree of sociocultural marginalization in the population with prostate cancer analyzed, as well as associated risk factors that limited the indication for treatments with curative intent. Said factors negatively impacted adequate patient follow-up.